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Abstract
Autophagy is a cell housekeeping mechanism that has recently received attention in relation to its effects on the immune
response. Genetic studies have identified candidate loci for Crohn’s disease susceptibility among autophagy genes, while
experiments in murine macrophages from ATG16L1 deficient mice have shown that disruption of autophagy increases
processing of IL-1b and IL-18 through an inflammasome-dependent manner. Using complementary approaches either
inducing or inhibiting autophagy, we describe modulatory effects of autophagy on proinflammatory cytokine production in
human cells. Inhibition of basal autophagy in human peripheral blood mononuclear cells (PBMCs) significantly enhances IL-
1b after stimulation with TLR2 or TLR4 ligands, while at the same time reducing the production of TNFa. In line with this,
induction of autophagy by starvation inhibited IL-1b production. These effects of autophagy were not exerted at the
processing step, as inflammasome activation was not influenced. In contrast, the effect of autophagy on cytokine
production was on transcription level, and possibly involving the inhibition of p38 mitogen activated protein kinase (MAPK)
phosphorylation. In conclusion, autophagy modulates the secretion of proinflammatory cytokines in human cells through
an inflammasome-independent pathway, and this is a novel mechanism that may be targeted in inflammatory diseases.
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Introduction
Autophagy is a conserved mechanism for degradation of
defective organelles and long-lived proteins, that plays an
important role in the homeostasis of the cell by recycling
cytoplasmic cargo for aminoacid and energy re-use [1]. Autophagy
comprises three main processes – chaperone-mediated autophagy,
microautophagy and macroautophagy. The latter, henceforth
referred to as autophagy, is characterized by the sequestration of
cytosolic proteins and organelles into double-membrane vesicles
called autophagosomes. These autophagosomes maturate through
fusion with lysosomes, a process that will eventually lead to the
breakdown of the protein content [2]. Through these effects,
autophagy has been demonstrated to be a biological response of
the cell in stressful situations, traditionally during starvation and
growth factor deprivation, ensuring the degradation of old
structures with the purpose of sustaining the essential anabolic
processes of the cell [3]. Consequently, through its main roles in
survival and housekeeping, the process of autophagy has gained
relevance in the context of human pathologies like neurodegen-
erative diseases [4], cancer [5], lysosomal diseases [6], and ageing
[1].
In addition to its role in cell survival, autophagy is emerging as a
process of high importance for the host defense, influencing both
the innate and adaptive immune responses [7]. This role is exerted
at three levels [8]: direct involvement in engulfment and removal
of intracellular pathogens [9,10], facilitation of the MHC class II
antigen presentation [11], and support of the T-lymphocyte
development and survival for optimal protective immune respons-
es [12,13]. Whether the involvement of autophagy in the immune
processes is due to the autophagic mechanism itself or to
independent effects of autophagy-related genes [14], is still a
matter of debate.
Genetic studies [15–17] have identified allelic variants of the
autophagy genes ATG16L1 (autophagy related 16-like 1) and
IRGM (immunity related GTP-ases, M) as important risk factors
for Crohn’s disease, an autoinflammatory disease characterized by
severe chronic inflammation of the gut mucosa [18,19]. One
possible explanation for the involvement of defective autophagy in
Crohn’s disease inflammation couples the risk alleles in ATG16L1
and NOD2 (nucleotide-binding oligomerization domain containing
2) to an impaired clearance of microorganisms [20,21]. The
persistence of bacteria in the mucosa could induce an inflamma-
tory reaction, leading to the clinical features of Crohn’s disease. An
alternative explanation has also been proposed by Saitoh et al.,
who demonstrated that the disruption of autophagy in ATG16L1-
deficient murine macrophages enhances the LPS-induced IL-1b
production through an inflammasome-dependent pathway [22].
However, whether autophagy has similar inhibitory effects in
human cells is not known.
In the present study, we assessed the effect of autophagy on the
production of proinflammatory cytokines in human cells. By
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stimulating human peripheral blood mononuclear cells (PBMCs),
we show that the inhibition of autophagy increases IL-1b
production after stimulation with TLR2 or TLR4 ligands. These
effects were specific for the modulation of IL-1b secretion, while
TNFa production was significantly reduced by agents that
inhibited autophagy. In contrast to murine macrophages, these
effects on human cells were exerted at the transcriptional level,
rather than at the level of the inflammasome.
Results
Western blot assessment of autophagy marker LC3-II
shows that starvation induces, whereas 3MA treatment
inhibits, the autophagic process
Microtubule associated protein 1 light chain 3 (LC3) is one
of the autophagy-related proteins involved in the direct
formation of the autophagosome. Through conjugation with
phosphatidylethanolamine, the cytosolic LC3-I is transformed
to LC3-II which is then bound to the autophagosome
membrane, being indicative of autophagic activity inside the
cell [23]. In order to verify the modulation of autophagy using
the typical induction method by starvation and the inhibition
method using the pharmacological inhibitor 3-Methyl Adenine
(3MA) in the human PBMCs system used in this study,
Western blotting of the two LC3 fractions was performed.
Freshly isolated human PBMCs treated with the starvation
medium EBSS (Earle’s Balanced Salt Solution) showed a
markedly increased level of LC3-II compared to RPMI
controls. Moreover, when 3MA was added, the LC3-II fraction
was decreased (Figure 1), attesting to the validity of the
classical autophagy methodologies in human PBMCs.
Inhibition of autophagy enhances IL-1b production while
decreasing TNFa in human PBMCs
To assess its effect on the cytokine production, autophagy was
inhibited using 3MA, a blocker of the Beclin-1 complex that
regulates the initiation of autophagy. PBMCs treated with 3MA
showed a significant higher IL-1b secretion after stimulations with
TLR2 or TLR4 ligands (Figure 2A). In contrast, TNFa production
was diminished in cells conditioned with 3MA compared to
controls (Figure 2B). No specific trend for the effect of 3MA on IL-
10 production was observed (Figure 2C).
Figure 1. Assessment of LC3 I and II levels in PBMCs under
starving conditions or pharmacological treatment with 3MA.
Human PBMCs were pre-incubated for 1 hour at 37uC in either RPMI,
starvation medium (EBSS) or EBSS with 3MA (10 mM) in which inhibitors
of lysosomal fusion have been added: Ammonium chloride 20 mM and
Leupeptine 100 mM. This was followed by 3 hours stimulation with
culture medium, LPS (10 ng/ml) or Pam3Cys (10 mg/ml) prepared in the
corresponding media (RPMI or EBSS). Cells were lysed and western blot
of LC3 fractions I and II has been performed.
doi:10.1371/journal.pone.0018666.g001
Figure 2. Modulation of inflammatory cytokine production by
autophagy inhibition. Freshly isolated human PBMCs were pre-
incubated for 1 hour at 37uC in culture medium in the presence or
absence of 3MA (10 mM) and afterwards stimulated with culture
medium, LPS (10 ng/ml) or Pam3Cys (10 mg/ml). After 24 hours
incubation, IL-1b (A), TNFa (B) and IL-10 (C) were measured in the
supernatant by specific ELISA. Data are presented as means 6 SEM of
cells harvested from 15 volunteers, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0018666.g002
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The modulation of IL-1b and TNFa production is
regulated at the transcriptional level
To identify the level in the cytokine production which is
modulated by 3MA, we assessed its effect on transcription and
processing of IL-1b. IL-1b mRNA levels were increased in human
PBMCs in the presence of 3MA (Figure 3A). Similarly, RT-PCR for
TNFa mRNA revealed that the inhibitory effect of 3MA on TNFa
production starts with the decrease of the TNFa transcription rate
(Figure 3B). On the other hand, western blot analysis of caspase-1
did not show an increased caspase-1 activation (p35 fragment) by
3MA compared to controls (Figure 3C).
3MA has an inhibitory effect on the ATP-dependent
release of IL-1b
It is known that the inflammasome activator ATP (adenosine
triphosphate) is a potent stimulator of IL-1b processing and release
[24]. In experiments aiming to assess how this effect is influenced
in the circumstances of autophagy inhibition, control PBMCs
showed a significantly higher increase (5.73 fold) of secreted IL-1b
when exposed to ATP then in samples treated with 3MA (2.25 fold
increase) (Figure 4).
Induction of autophagy by starvation inhibits IL-1b
transcription
In an additional set of experiments, we pursued to verify
whether consistent findings with those revealed when inhibiting
autophagy could be seen in the context of autophagy induction,
typically obtained during starvation. In line with the effects
observed by the experiments using 3MA, starvation reduced the
transcription of IL-1b after LPS or Pam3Cys stimulation of cells
(Figure 5A). Furthermore, these effects of starvation were reversed
by 3MA, demonstrating the involvement of autophagy in the
effects of starvation (Figure 5B). In contrast to its effect on IL-1b,
starvation inhibited TNFa mRNA, but 3MA decreased even
further TNFa transcription. This observation is consistent with the
experiments showed earlier that 3MA reduces the TNFa gene
transcription.
The role of MAP kinases for the modulatory effects of
autophagy inhibition by 3MA
Mitogen-activated protein kinases (MAPKs) such as ERK1/2
(activated by MEK), JNK or p38 are important intracellular
mediators of the stimulation of pro-inflammatory cytokine
production during innate immune responses [25]. In order to
decipher the mechanism through which autophagy inhibition
modulates cytokine transcription, we investigated the effects of
MAPK inhibition on the 3MA-dependent variation of cytokine
production. Cells pre-treated with inhibitors of MEK, JNK or p38
in the presence or absence of 3MA have further been stimulated
with LPS and Pam3Cys and cytokine production is depicted in
Figure 6 (panels A and B for IL-1b; C and D for TNFa). With all
inhibitors, except p38i, 3MA had similar consequences on the
cytokine production, consisting in increasing IL-1b and decreasing
TNFa secretion after both LPS and Pam3Cys stimulation.
Nevertheless, when using p38i, lower IL-1b concentrations were
measured in samples treated with 3MA after Pam3Cys stimulation
than in controls. Consequently, in order to test the hypothesis of
p38 being involved in the effects of 3MA, we performed Western
blots of total and phosphorylated (active) p38 which revealed that
in samples treated with the autophagy inhibitor, the phosphory-
lated fraction of p38 is lower than in controls, after TLR4 or
TLR2 stimulations (Figure 6E). Furthermore, the slight induction
of TNFa and IL-1b by 3MA alone was shown to be dependent on
p38 MAPK signaling (3MA: IL-1b 6656135 pg/ml, TNFa
215645 pg/ml and 3MA+p38i: IL-1b 20610 pg/ml, TNFa
40615 pg/ml; p,0.05 for both IL-1b and TNFa).
Discussion
Earlier studies linked autophagy to innate immunity as a defense
system against invading pathogens in nonphagocytic cells [26].
Later it has been also demonstrated that autophagy regulates
pathogen-associated molecular pattern (PAMP) recognition by
facilitating TLR stimulation in response to viral antigens [27].
Subsequently, it has been discovered that components of the
autophagy machinery are used for intracellular degradation of
bacteria and MHC-II dependent activation of specific immunity
[9]. These effects could prove very relevant, as genetic poly-
morphisms of the autophagy genes ATG16L1 and IRGM are
associated with Crohn’s disease [15–17]. In addition, deletion of
the autophagy gene ATG16L1 in mice resulted in inflammasome
activation and more severe experimental colitis [22]. However, the
effect of autophagy on IL-1b production was demonstrated only in
murine cells, and no information was available whether similar
effects may be exerted in human cells.
In the present study, using a complementary approach by both
inhibition and induction of autophagy as verified using the LC3-II
marker, we show that autophagy has strong inhibitory effects on
IL-1b production. These results add to the increasing body of
evidence showing that basal autophagy in physiological conditions
has important modulatory effects on inflammation [22,28].
However, in contrast to murine cells, autophagy did not inhibit
inflammasome activation in human PBMCs, and its effects were
the consequence of the modulatory effect on transcription of
cytokine genes. These data point out once again that inflamma-
some activation and regulation differs greatly in human PBMCs
and murine macrophages, as inflammasome activation is consti-
tutive in human monocytes, but not in mouse macrophages [29].
Subsequently, in human PBMCs, caspase-1 activation is not
increased by autophagy inhibition. In addition, the assessment of
ATP/inflammasome-dependent release of IL-1b shows that this is
not increased in the presence of 3MA compared to controls. This
would suggest that although the cytokine release appears to be
slightly inhibited on the short term (15 minutes after ATP
addition), transcriptional regulation is sufficient to determine the
higher levels obtained in longer stimulations. These findings
confirm that the increase of IL-1b production during autophagy
inhibition is determined by the activation of transcription and is
not due to the influence on the subsequent steps of processing by
caspase-1 or secretion from the intracellular compartment.
In the attempt to point out to the mechanism underlying the
effect of autophagy on gene transcription, we have tested the
importance of several MAPK-dependent mechanisms and ob-
served that the only condition that reversed the stimulatory effects
of 3MA was the p38 inhibitor SB202190. As there is evidence of
this inhibitor also influencing Rip2 activation [30], the observed
effect might also be involving other p38-related MAP kinases in
addition to p38. However, while these results have led us to the
hypothesis that p38 activation might be important for the effect of
3MA on IL-1b, this was not confirmed by Western blot analysis, as
phosphorylated p38 (active form) was decreased in 3MA treated
samples. However, in line with earlier evidence showing that p38
phosphorylation is positively linked to the process of autophagy
[31,32], 3MA treatment led to inhibition of p38 phosphorylation
and this could, at least in part, represent a pathway of autophagy
effect on TNFa release. In summary, while the inhibitory effects of
3MA on p38 phosphorylation can explain its effect on TNFa
Autophagy and Inflammatory Cytokines
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Figure 3. The effects of 3MA on transcription and processing of inflammatory cytokines. Cells pre-treated for 1 hour with culture medium
with or without 3MA (10 mM) were stimulated for 4 hours with RPMI, LPS (10 ng/ml) or Pam3Cys (10 mg/ml). RT-PCR was performed and relative
levels of IL-1b and TNFa (B) mRNA were determined in 4 volunteers. (C) Western blot of p35 caspase-1 after 1 hour pre-incubation with or without
3MA (10 mM in RPMI), followed by 2 hours stimulation with LPS (10 ng/ml). The picture is representative for results obtained from 6 volunteers.
doi:10.1371/journal.pone.0018666.g003
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production, this cannot be the cause of the potentiation of IL-1b
transcription, and further studies are needed to decipher this
aspect.
Recently, two new studies have also reported that the
peptidoglycan receptor NOD2, whose gene is considered a
susceptibility locus for Crohn’s disease, is linked to autophagy by
recruiting ATG16L1 at the site of the microbial entry within the
infected cell [21], directing microbial engulfment in the autopha-
gosome and inducing antigen presentation [20]. These latest two
studies represent the connection between the two genetic pathways
that induce susceptibility to Crohn’s disease: NOD2 and
autophagy. Crohn’s disease is a chronic inflammatory reaction
in the gut mucosa, and recent studies strongly suggested a role of
autophagy in this process. On the one hand, autophagy seems to
be crucial for the homeostasis of Paneth cells. Mice with a
defective ATG16L1 display abnormal Paneth cells with a lower
amount of granules containing antibacterial defensins, while in
turn displaying an increased IL-1b production [28]. These effects
could lead to bacterial persistence in the mucosa and overwhelm-
ing inflammation. The studies by Cooney et al. [20] and Travassos
et al. [21] show for the first time that a decreased autophagy in
humans can lead to decreased bacterial clearance, while our study
provides evidence that diminished autophagy in human cells (e.g.
through pharmacological inhibition as shown here, or through
genetic mutations in Crohn’s disease) could lead to uncontrolled
IL-1b production.
The differential findings in mice and humans concerning the
modulation of IL-1b by autophagy, transcription in humans and
caspase-1 activation in mice, remains to be elucidated. One
possible explanation lies in the different cell populations studied:
monocytes in our study in humans versus macrophages in the
mouse studies. We have previously shown clear differential
regulation of the caspase-1 inflammasome in monocytes (consti-
tutive activation) versus macrophages (inducible activation) [29].
Another source of difference could be species specificity, an aspect
which in terms of the autophagy-inflammation interaction is still
largely unknown. This is an aspect which certainly deserves
attention in future studies, and the present study represents an
important first step in this direction.
In conclusion, this study is the first attempt to investigate the
modulation of inflammatory cytokines by the process of autophagy
in humans. We have shown that disruption of autophagy has an
important impact on inflammatory cytokine modulation, deter-
mining a remarkable and specific increase of IL-1b secretion,
while decreasing TNFa production. We demonstrate that the
inflammasome activation is not influenced in human PBMCs and
that the changes are exerted at the gene transcription level.
Although the p38 MAPK pathway seems to be linked to the
autophagy process and our findings may explain the effects on
TNFa production through modulation of p38 phosphorylation,
this is probably not the mechanism of the observed higher IL-1b
mRNA levels in the circumstances of autophagy inhibition.
Further assessment of the mechanisms through which inflamma-
tion is regulated by autophagy may bring new opportunities for the
understanding and treatment of autoinflammatory disorders such
as Crohn’s disease.
Materials and Methods
Reagents
3-Methyl Adenine (3MA) was purchased from Sigma (St. Louis,
MO). LPS (E. coli serotype 055:B5) was purchased from Sigma.
Synthetic Pam3Cys was purchased from EMC Microcollections
(Tubingen, Germany). Anti-actin (A2066) antibody was purchased
from Sigma; anti-human caspase-1 p10 (sc515) antibody was
purchased from Santa Cruz Biotechnologies (Santa Cruz, CA);
anti-human/mouse LC3B antibody (NB600-1384) was purchased
from Novus Biologicals (Cambridge, UK); anti-human total p38
antibody (CS9212) and phosphorylated p38 antibody (Phospho
p38 MAPK Thr180/Tyr182 Antibody, CS4511) were purchased
from Cell Signaling (Danvers, MA). oxATP was purchased from
Sigma. SB202190 p38/Rip2 MAPK inhibitor (p38i); SP600125,
JNK1/2/3 inhibitor (JNKi) and U0126 MEK1/2 inhibitor
(MEKi) were purchased from Superarray Bioscience Corporation
(Bethesda, MD). In experiments using pharmacological inhibitors,
control cells were treated with an equivalent concentration of
vehicle (0.1% DMSO).
PBMC isolation and stimulation
Peripheral blood was harvested from the antecubital vein of
healthy volunteers, after obtaining informed consent. The PBMC
fraction was obtained by differential centrifugation over Ficoll-
Paque (Sigma). Cells adjusted to 56106 cells/ml were suspended
in culture medium RPMI (Roswell Park Memorial Institute) 1640,
supplemented with 50 mg/ml gentamicin, 2 mM L-glutamine and
1 mM pyruvate. All cytokine induction experiments were
performed in duplicate wells. Cells were pre-incubated for 1 hour
at 37uC in culture medium or in the presence of 3MA (10 mM).
After the pre-treatment, RPMI (negative controls), purified LPS
(10 ng/ml) or Pam3Cys (10 mg/ml) was added to the cells. In
separate experiments, cells were first incubated for 1 h with
RPMI, MEK inhibitor (5 mM), JNK inhibitor (20 mM) or p38
inhibitor (1 mM) before performing the steps described above.
After 24 hours, the supernatants were collected and stored at
220uC until assayed.
To investigate the effect of 3MA on the ATP-dependent IL-1b
release, cells pre-treated for 1 hour with RPMI with or without
10 mM 3MA were stimulated for 4 hours with LPS (10 ng/ml or
1 mg/ml). After the stimulation, supernatants were discarded and
refreshed with RPMI containing 1mM ATP, after which the cells
Figure 4. The influence of 3MA on the ATP-dependent release
of IL-1b. PBMCs were pre-incubated for 1 hour in the presence or
absence of 3MA and were stimulated for 4 hours with LPS (10 ng/ml).
After the stimulation, supernatants were discarded and refreshed with
RPMI or with RPMI containing 1 mM ATP and cells were incubated for
another 15 min. Data are shown as mean 6 SEM of supernatant IL-1b
levels obtained in 8 volunteers, **p,0.01.
doi:10.1371/journal.pone.0018666.g004
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were incubated for another 15 min. The LPS-dependent IL-1b
production during the first 4 hours, and the ATP-dependent IL-1b
secretion after the additional 15 minutes, was assessed in the
supernatant.
Autophagy induction was performed in adherent monocytes
using starvation medium, Earle’s Balanced Salt Solution, EBSS
(Invitrogen, Carlsbad, California). PBMCs were incubated for
1 hour after which the supernatant containing the non-adherent
lymphocytes was discarded. Adherent cells were pre-treated for
2 hours with starvation medium. Subsequently, cells were
stimulated for 4 hours with LPS or Pam3Cys prepared in
starvation medium. In parallel, controls were given the same
treatment using RPMI. After 4 hours, supernatants were discard-
ed and TRIzol Reagent was added to the cells which were
subsequently frozen and stored at 280uC until assayed. In
different experiments, 3MA was also used in combination with
starvation medium to investigate whether the effects of starvation
are reversed by 3MA.
Both experiments involving stimulation or inhibition of
autophagy were performed with cells isolated from the same
healthy volunteers. However, in some experiments in which not all
experiments could be performed with blood collected from the
same volunteers, studies were done in cells collected from
additional healthy volunteers.
Cytokine measurements
Cytokine concentrations were determined using specific sand-
wich ELISA kits for IL-1b, TNFa (R&D Systems), and IL-10
(Sanquin).
RT-PCR
Samples stimulated for 4 hours at 37uC were treated with
TRIzol Reagent (Invitrogen) and total RNA purification was
performed according to manufacturer’s instructions. Isolated RNA
was subsequently transcribed into complementary DNA using
iScript cDNA Synthesis Kit (Bio-Rad) followed by quantitative
PCR using the Sybr Green method. The following primers were
used in the reaction: IL-1b forward 59-GCCCTAAACAGAT
GAAGTGCTC-39 and reverse 59-GAACCAGCATCTTCCT
CAG-39, TNFa forward 59-TGGCCCAGGCAGTCAGA-39
and reverse 59-GGTTTGCTACAACATGGGCTACA-39, b2-
microglobulin forward 59-ATGAGTATGCCTGCCGTGTG-39
and reverse 59-CCAAATGCGGCATCTTCAAAC-39 (Biolegio).
Results are shown as fold increases in mRNA levels in stimulated
samples compared to controls. Quantitative PCR for cytokines was
used especially in short-term induction of autophagy experiments
using starvation medium, in which long-term incubation led to a
high percentage of cell death, and in which ELISA cytokine
measurements in the supernatants were not able to provide an
appropriate assessment of cytokine stimulation.
Figure 5. The effects of starvation on mRNA levels of
inflammatory cytokines. Cells pre-incubated for 2 hours in either
starvation medium (Earle’s Balanced Salt Solution) or RPMI were
stimulated for 4 hours with medium, LPS (10 ng/ml) or Pam3Cys
(10 mg/ml) prepared respectively in starvation medium or RPMI.
Subsequently, RT-PCR was performed and IL-1b mRNA levels are
depicted as mean 6 SEM of cells harvested from 6 volunteers, *p,0.05
(A). RT-PCR results of IL-1b (B) and TNFa (C) mRNA levels in cells pre-
incubated for 2 hours with RPMI, starvation medium or starvation
medium and 3MA (10 mM) followed by 4 hours stimulation with RPMI
or LPS (10 ng/ml). Results are shown as mean 6 SEM of data obtained
in 4 volunteers.
doi:10.1371/journal.pone.0018666.g005
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Western blot
For western blotting of actin, caspase-1 and p38 MAPK (total
and phosphorylated), 56106 cells were lysed in 100 ml lysis buffer
(50 mM Tris, pH 7.4, 150 mM NaCl, 2 mM EDTA, 2 mM
EGTA, 10% glycerol, 1% Triton X-100, 40 mM b-glycerophos-
phate, 50 mM sodium fluoride, 200 mM sodium orthovanadate,
complete mini EDTA-free protease inhibitor cocktail (Roche) and
PhosSTOP Phosphatase Inhibitor Cocktail (Roche)). The homog-
enate was stored at 220uC. When needed, samples were thawed,
then centrifuged for 10 min at 14,000 rpm, and the supernatant
was taken for western blotting. Equal amounts of protein were
subjected to SDS-PAGE electrophoresis using 12% polyacryl-
amide gels at a voltage of 100V. After separation, proteins were
transferred to polyvinylidene fluoride (PVDF) membrane using the
dry blotting method (iBlotTM, Invitrogen). The membrane was
blocked with 5% (w/v) milk powder in Tris-buffered saline/Tween
20 (TBST) for 1 hour at room temperature followed by incubation
over night at 4uC with the primary antibody 1:500 in 5% (w/v)
BSA/TBST (5% bovine serum albumin/TBST). After overnight
incubation the blots were washed three times with TBST and
incubated with HRP-conjugated anti-rabbit antibody at a dilution
of 1:5000 in 5% (w/v) milk powder in TBST for 1 hour at room
temperature. After washing three times with TBST the blots were
developed using ECL Plus Western Blot Detection Reagents
(Amersham Biosciences, Buckinghamshire, UK). For western
blotting of LC3, an amount of 106106 cells were lysed after
Figure 6. MAPK influence on the 3MA-dependent modulation of IL-1b and TNFa production. PBMC samples conditioned for 1 hour in
either medium or in the presence of MAPK inhibitors: MEK inhibitor (5 mM), JNK inhibitor (20 mM) or p38 inhibitor (1 mM) were subjected to 1 hour
treatment with RPMI or 3MA (10 mM), followed by stimulation with RPMI, LPS (10 ng/ml) or Pam3Cys (10 mg/ml). After 24 hours incubation, specific
ELISA was performed to determine the level of IL-1b in response to LPS (A) and Pam3Cys (B) stimulations, same as for TNFa (panels C and D,
respectively). Data from 6 volunteers are shown as mean6 SEM. (E) Western blot of total and phosphorylated p38 in cells pre-treated for 1 hour with
RPMI or 3MA (10 mM) and subjected to 1 hour stimulation with RPMI, LPS (10 ng/ml) or Pam3Cys (10 mg/ml). (F) Quantification of the effect of 3MA
on the phosphorylation of p38.
doi:10.1371/journal.pone.0018666.g006
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being cultured in media containing the inhibitors of lysosomal
fusion, ammonium chloride,20 mM, and leupeptine,100 mM.
After protein electrophoresis in 15% polyacrylamide gel, the
transfer was performed on nitroglycerine membranes using the
wet blotting method (Bio-Rad) and was followed by blocking,
incubation with first and then second antibody, each time using
5% (w/v) milk powder in Tris-buffered saline/Tween 20 (TBS-T).
After washing 3 times with TBS-T, blots were developed using the
Super SignalH West Femto Maximum Sensitivity Substrate
(Thermo Scientific, Rockford, IL, USA) according to the
manufacturer’s instructions. Quantitative assessment of band
intensity was performed by Image Lab statistical software (Bio-
Rad, CA, USA).
Statistical analysis
The differences were analysed using Wilcoxon signed rank test
and were considered statistically significant at a p-value,0.05.
Data are shown as cumulative results of levels obtained in all
volunteers (means 6 SEM).
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